Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue 8
Submit an article Journal homepage
346
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Personalized immunotherapy (AGS-003) when combined with sunitinib for the treatment of metastatic renal cell carcinoma

Robert A FiglinCedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA, [email protected]
, MD FACP (Steven Spielberg Family Chair in Hematology Oncology, Professor of Medicine and Biomedical Sciences, Director of the Division of Hematology Oncology, Deputy Director of Samuel Oschin Comprehensive Cancer Institute)
Pages 1241-1248 | Published online: 30 Jun 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Camillo Porta, Ilaria Toscani, Anna M. Czarnecka & Cezary A. Szczylik. (2017) Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents. Expert Opinion on Biological Therapy 17:2, pages 151-162.
Read now

Articles from other publishers (15)

Juan Jin, Yuhao Xie, Jin-Shi Zhang, Jing-Quan Wang, Shi-Jie Dai, Wen-fang He, Shou-Ye Li, Charles R. AshbyJr.Jr., Zhe-Sheng Chen & Qiang He. (2023) Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resistance Updates 67, pages 100929.
Crossref
Diana Campillo-Davo, Maxime De Laere, Gils Roex, Maarten Versteven, Donovan Flumens, Zwi N. Berneman, Viggo F. I. Van Tendeloo, Sébastien Anguille & Eva Lion. (2021) The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy. Pharmaceutics 13:3, pages 396.
Crossref
Thiruganesh Ramasamy, Shankar Munusamy, Hima Bindu Ruttala & Jong Oh Kim. (2020) Smart Nanocarriers for the Delivery of Nucleic Acid‐Based Therapeutics: A Comprehensive Review. Biotechnology Journal 16:2, pages 1900408.
Crossref
Le Qu, Ding Wu, Haowei He, Xiaofeng Xu & Cheng Chen. 2020. Evolving Trends in Kidney Cancer. Evolving Trends in Kidney Cancer.
Yuhua Weng, Qianqian Huang, Chunhui Li, Yongfeng Yang, Xiaoxia Wang, Jie Yu, Yuanyu Huang & Xing-Jie Liang. (2020) Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology. Molecular Therapy - Nucleic Acids 19, pages 581-601.
Crossref
Frank Peinemann, Susanne Unverzagt, Andreas V Hadjinicolaou & Ines Moldenhauer. (2019) Immunotherapy for metastatic renal cell carcinoma: A systematic review. Journal of Evidence-Based Medicine 12:4, pages 253-262.
Crossref
Lorna W. Harries. (2019) RNA Biology Provides New Therapeutic Targets for Human Disease. Frontiers in Genetics 10.
Crossref
Wouter W. van Willigen, Martine Bloemendal, Winald R. Gerritsen, Gerty Schreibelt, I. Jolanda M. de Vries & Kalijn F. Bol. (2018) Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time. Frontiers in Immunology 9.
Crossref
Susanne Unverzagt, Ines Moldenhauer, Monika Nothacker, Dorothea Roßmeißl, Andreas V Hadjinicolaou, Frank Peinemann, Francesco Greco & Barbara Seliger. (2017) Immunotherapy for metastatic renal cell carcinoma. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Yang Hyun ChoMyung Soo KimHo Seok ChungEu Chang Hwang. (2017) Novel immunotherapy in metastatic renal cell carcinoma. Investigative and Clinical Urology 58:4, pages 220.
Crossref
Robert J. Motzer, Bernard Escudier, Andrew Gannon & Robert A. Figlin. (2017) Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma. The Oncologist 22:1, pages 41-52.
Crossref
A. Lapeyre-Prost, M. Terme, S. Pernot, A.-L. Pointet, T. Voron, E. Tartour & J. Taieb. 2017. 295 342 .
Yongsheng Chen, Lichen Teng, Wenhua Liu, Yan Cao, Dexin Ding, Wentao Wang, Hui Chen, Changfu Li & Ruihua An. (2016) Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach. Cancer Cell International 16:1.
Crossref
Ronald J Fecek & Walter J Storkus. (2016) Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines. Immunotherapy 8:10, pages 1205-1218.
Crossref
Maria I. Carlo, Martin H. Voss & Robert J. Motzer. (2016) Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma. Nature Reviews Urology 13:7, pages 420-431.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.